Ben Zeskind, PhD, MBA (CEO)
After earning a PhD at MIT in Biological Engineering and an MBA at Harvard Business School, Dr. Zeskind founded Immuneering to help pharma companies maximize the success of medicines. More …
Bob Carpenter (Chairman)
Mr. Carpenter served on Genzyme’s Board of Directors from 1994-2011. He was chairman of the board, president, and CEO of Integrated Genetics Inc., a biotechnology company that merged with Genzyme in 1989. More …
Prof. Doug Lauffenburger, PhD (Scientific Advisory Board Co-Chair)
Prof. Lauffenburger is the head of MIT’s Department of Biological Engineering and a pioneer in applying engineering principles to biological research. More …
Max Artyomov, PhD (Scientific Advisory Board Co-Chair)
Dr. Artyomov is an Assistant Professor of Immunology and Pathology at Washington University in St. Louis. He conducted postdoctoral research at the Broad Institute of MIT and Harvard.
More …
Kevin D. Fowler, PhD (VP, Translational Research)
Dr. Fowler earned a PhD at MIT in Chemical Engineering, focused on computational immunology and signal integration in immune cell biology, and conducted research at Harvard Medical School. More …
Fadi Towfic, PhD (VP, Computational Medicine)
Dr. Towfic conducted postdoctoral research at the Broad Institute of MIT and Harvard, and the Massachusetts General Hospital (MGH) Center for Computational and Integrative Biology.
More …
Jason Funt, PhD (VP, Computational Biology)
Dr. Funt earned a PhD in Computational and Systems Biology at MIT, conducting research at the Broad Institute of MIT and Harvard. More …
Sarah Kolitz, PhD (Director, Translational Research)
Dr. Kolitz joined Immuneering after conducting postdoctoral research at MIT in Biological Engineering, and earning a PhD in Biophysics at Johns Hopkins.More …
Neda Bagheri, PhD (Scientific Advisory Board)
Dr. Bagheri is an Assistant Professor at Northwestern University. She conducted postdoctoral research at MIT. More …

 


Ben Zeskind, PhD, MBA
Co-Founder and CEO

After earning a PhD at MIT in Biological Engineering and an MBA at Harvard Business School, Dr. Zeskind founded Immuneering to help pharma companies maximize the success of medicines through insights into the underlying biological mechanisms. His PhD research at MIT led to a first author publication in Nature Methods and two issued U.S. Patents. At Harvard Business School, he was recognized as a Baker Scholar, the highest award for distinction. Dr. Zeskind has worked at Merck’s Global Marketing Division, IBM, Constant Contact, Bose, and the US  Army Natick Labs. He can be reached via email at Benjamin.J.Zeskind at Immuneering.com. His publications include:

Maximizing the efficacy of angiogenesis inhibitors, Journal of Clinical Oncology, 2012
Lebrikizumab treatment in adults with asthma, New England Journal of Medicine, 2011
Nucleic acid and protein mass mapping by live-cell deep-ultraviolet microscopy, Nature Methods, 2007
Full Publication List …

 

Bob Carpenter
Co-Founder and Chairman

Mr. Carpenter served on Genzyme’s Board of Directors from 1994-2011. He was chairman of the board, president, and CEO of Integrated Genetics Inc., a biotechnology company that merged with Genzyme in 1989. Following the merger and until 1991, he was executive vice president of Genzyme and CEO and chairman of the board of IG Laboratories Inc. From 1991 until it merged with Genzyme in 2000, Mr. Carpenter was chairman of GelTex Pharmaceuticals Inc., which he co-founded in 1991 and where he served as president and CEO until 1993. He also co-founded VacTex Inc., and served as its president and CEO from 1995 until its acquisition by Aquila Biopharmaceuticals Inc. in 1998. He is also the chairman of Hydra Biosciences.

Prof. Doug Lauffenburger, PhD
Scientific Advisory Board Co-Chair

Prof. Lauffenburger is the head of MIT’s Department of Biological Engineering and a pioneer in applying engineering principles to biological research. His expertise spans multiple disciplines including chemical engineering, bioengineering, biotechnology process engineering, biophysics, quantitative cell and structural biology, systems biology, and applied mathematics. He has filed numerous patents, authored a key textbook on receptor-ligand binding and trafficking dynamics, and published over 200 peer-reviewed articles including:

Polyfunctional responses by human T cells result from sequential release of cytokines, PNAS, 2012
A mammalian functional-genetic approach to characterizing cancer therapeutics, Nature Chemical Biology, 2011
Impaired SHP2-mediated extracellular signal-regulated kinase activation contributes to gefitinib sensitivity of lung cancer cells with epidermal growth factor receptor-activating mutations, Cancer Research, 2010
Full Publication List …

Assistant Professor Max Artyomov, PhD
Scientific Advisory Board Co-Chair

Dr. Artyomov is an Assistant Professor of Immunology and Pathology at Washington University in St. Louis. He conducted postdoctoral research at the Broad Institute of MIT and Harvard, and previously earned a PhD at MIT in Chemistry, with a focus on computational immunology. His publications include:

Systematic discovery of TLR signaling components delineates viral-sensing circuits, Cell, 2011

Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation, Nature, 2010

CD4 and CD8 binding to MHC molecules primarily acts to enhance Lck delivery, PNAS, 2010

Full Publication List …

Kevin D. Fowler, PhD
VP, Translational Research

Dr. Fowler earned a PhD at MIT in Chemical Engineering, with a focus on computational immunology and signal integration in immune cell biology, and conducted research at Harvard Medical School. He can be reached via email at Kevin.D.Fowler at Immuneering.com. His publications include:

A model for how signal duration can determine distinct outcomes of gene transcription programs, PLoS One, 2012
HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide, Nature Immunology, 2011

Empty class II major histocompatibility complex created by peptide photolysis establishes the role of DM in peptide association, JBC, 2007

Full Publication List …

Fadi Towfic, PhD
VP, Computational Medicine

Dr. Towfic conducted postdoctoral research at the Broad Institute of MIT and Harvard, and the Massachusetts General Hospital (MGH) Center for Computational and Integrative Biology. He earned a PhD in Bioinformatics and Computational Biology at Iowa State University. He can be reached via email at Fadi.G.Towfic at Immuneering.com. His publications include:

Genome-wide siRNA screen for mediators of NF-κB activation, PNAS, 2012

Shape-based feature matching improves protein identification via LC-MS and tandem MS, Journal of Computational Biology, 2011

Detection of gene orthology from gene co-expression and protein interaction networks, BMC Bioinformatics, 2010

Full Publication List …

Jason Funt, PhD
VP, Computational Biology

Dr. Funt earned a PhD in Computational and Systems Biology at MIT, conducting research at the Broad Institute of MIT and Harvard. He can be reached via email at Jason.M.Funt at Immuneering.com. His publications include:

Determinants of divergent adaptation and Dobzhansky-Muller interaction in experimental yeast populations, Current Biology, 2010
Full Publication List …

Sarah Kolitz, PhD
Director, Translational Research

Dr. Kolitz conducted postdoctoral research in Biological Engineering at MIT. She previously earned a PhD in Biophysics from Johns Hopkins University. Her publications include:

Measurement and modeling of signaling at the single-cell level, Biochemistry, 2012
Eukaryotic initiator tRNA: finely tuned and ready for action, FEBS Letters, 2010
Kinetic and thermodynamic analysis of the role of start codon/anticodon base pairing during eukaryotic translation initiation, RNA, 2009
Full Publication List …

Assistant Professor Neda Bagheri, PhD
Scientific Advisory Board

Dr. Bagheri is an Assistant Professor at Northwestern University. She conducted postdoctoral research at MIT, and previously earned a PhD in Electrical and Computer Engineering (with a focus on Control Theory) at the University of California Santa Barbara. Her publications include:

Polyfunctional responses by human T cells result from sequential release of cytokines, PNAS, 2012
A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibition, PLoS Computational Biology, 2011
Circadian phase resetting via single and multiple control targets, PLoS Computational Biology, 2008
Full Publication List …